m v Search Results


90
Santa Cruz Biotechnology unc5b
Unc5b, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/unc5b/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
unc5b - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology hdac2 shrna m lentiviral particles
<t>HDAC2</t> in NSCs is a mediator for the role of neuronal nNOS–PSD-95 association in regulating the fate of NSCs. A, B, Immunoblots showing HDAC2 levels (n = 4; A) and bar graph showing the percentage of newborn neurons (n = 3; B) in the NSCs infected by LV-HDAC2-shRNA, LV-control-shRNA, AD-HDAC2-Flag, or AD-Flag. C, Bar graph showing the percentage of newborn neurons in the DG of rats infected by AD-HDAC2-Flag or AD-Flag (n = 9). These rats were subjected to MCAO at 24 h after virus infection and were killed for BrdU/DCX staining at day 14 after MCAO administration. D–F, Bar graphs showing the percentage of newborn neurons (D), the percentage of neurons with multineurites (E), and total neurite length per newborn neuron with multineurites (F) in the NSCs treated with DETA/NONOate (50 μm) with or without NO scavenger C-PTIO (10 μm) for 24 h at day 2 after differentiation. The cultures were stained 4–5 d after treatment. (n = 3). G, Nitrosylation of total proteins or HDAC2 in NSCs. NSCs were treated with 50 μm DETA/NONOate for the indicated times (G1), with 50 μm GSNO for 4 h (G2), or with 50 μm DETA/NONOate for 4 h (G3) at day 2 after differentiation (n = 4). PC, Positive control, in which the lysate of NSCs was treated with GSNO (200 μm) for 30 min; BSA, biotin-switch assay. H, Immunoblots showing HDAC2 levels in the NSCs treated with 50 μm DETA/NONOate for the indicated times at day 2 after differentiation. (n = 3–5). I, Bar graphs showing HDAC2 activity in the NSCs treated with 50 μm DETA/NONOate for the indicated times (left) or by 50 μm DETA/NONOate with or without 10 μm NO scavenger C-PTIO for 4 h (right) at day 2 after differentiation. n = 3–5. J, K, HDAC2 levels (J; n = 5) and enzymatic activity (K; n = 4) in the solo-cultured or neuron-cocultured NSCs with or without C-PTIO. All cultures were exposed to OGD for 2 h at day 2 after NSC differentiation, and the NSCs were collected 6 h after OGD finish. To measure HDAC2 in NSCs selectively, coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells. C-PTIO (10 μm) or vehicle was added to the medium of NSCs in wells at the start of OGD exposure. L, M, The percentage of newborn neurons (L) and the percentage of newborn neurons with multineurites (M) in the cocultures of LV-control-shRNA- or LV-HDAC2-shRNA-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h at day 2 after differentiation and stained at days 4∼5 after OGD (n = 4). N, O, Bar graphs showing the percentage of newborn neurons (N) and the percentage of newborn neurons with multineurites (O) in the cocultures of AD-HDAC2-flag- or AD-flag-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h and treated with 10 μm ZL006 for 26 h beginning at OGD administration, and were stained at days 4∼5 after OGD administration. n = 5. Data are the mean ± SEM. *p < 0.05, **p < 0.01, two-tailed t test for C, ANOVA for others.
Hdac2 Shrna M Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hdac2 shrna m lentiviral particles/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
hdac2 shrna m lentiviral particles - by Bioz Stars, 2026-04
88/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology mouse gata 6
<t>HDAC2</t> in NSCs is a mediator for the role of neuronal nNOS–PSD-95 association in regulating the fate of NSCs. A, B, Immunoblots showing HDAC2 levels (n = 4; A) and bar graph showing the percentage of newborn neurons (n = 3; B) in the NSCs infected by LV-HDAC2-shRNA, LV-control-shRNA, AD-HDAC2-Flag, or AD-Flag. C, Bar graph showing the percentage of newborn neurons in the DG of rats infected by AD-HDAC2-Flag or AD-Flag (n = 9). These rats were subjected to MCAO at 24 h after virus infection and were killed for BrdU/DCX staining at day 14 after MCAO administration. D–F, Bar graphs showing the percentage of newborn neurons (D), the percentage of neurons with multineurites (E), and total neurite length per newborn neuron with multineurites (F) in the NSCs treated with DETA/NONOate (50 μm) with or without NO scavenger C-PTIO (10 μm) for 24 h at day 2 after differentiation. The cultures were stained 4–5 d after treatment. (n = 3). G, Nitrosylation of total proteins or HDAC2 in NSCs. NSCs were treated with 50 μm DETA/NONOate for the indicated times (G1), with 50 μm GSNO for 4 h (G2), or with 50 μm DETA/NONOate for 4 h (G3) at day 2 after differentiation (n = 4). PC, Positive control, in which the lysate of NSCs was treated with GSNO (200 μm) for 30 min; BSA, biotin-switch assay. H, Immunoblots showing HDAC2 levels in the NSCs treated with 50 μm DETA/NONOate for the indicated times at day 2 after differentiation. (n = 3–5). I, Bar graphs showing HDAC2 activity in the NSCs treated with 50 μm DETA/NONOate for the indicated times (left) or by 50 μm DETA/NONOate with or without 10 μm NO scavenger C-PTIO for 4 h (right) at day 2 after differentiation. n = 3–5. J, K, HDAC2 levels (J; n = 5) and enzymatic activity (K; n = 4) in the solo-cultured or neuron-cocultured NSCs with or without C-PTIO. All cultures were exposed to OGD for 2 h at day 2 after NSC differentiation, and the NSCs were collected 6 h after OGD finish. To measure HDAC2 in NSCs selectively, coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells. C-PTIO (10 μm) or vehicle was added to the medium of NSCs in wells at the start of OGD exposure. L, M, The percentage of newborn neurons (L) and the percentage of newborn neurons with multineurites (M) in the cocultures of LV-control-shRNA- or LV-HDAC2-shRNA-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h at day 2 after differentiation and stained at days 4∼5 after OGD (n = 4). N, O, Bar graphs showing the percentage of newborn neurons (N) and the percentage of newborn neurons with multineurites (O) in the cocultures of AD-HDAC2-flag- or AD-flag-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h and treated with 10 μm ZL006 for 26 h beginning at OGD administration, and were stained at days 4∼5 after OGD administration. n = 5. Data are the mean ± SEM. *p < 0.05, **p < 0.01, two-tailed t test for C, ANOVA for others.
Mouse Gata 6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse gata 6/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
mouse gata 6 - by Bioz Stars, 2026-04
85/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology murine gαi3
Gαi1 and <t>Gαi3</t> DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)
Murine Gαi3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/murine gαi3/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
murine gαi3 - by Bioz Stars, 2026-04
88/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology sc 39053 v
Gαi1 and <t>Gαi3</t> DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)
Sc 39053 V, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sc 39053 v/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
sc 39053 v - by Bioz Stars, 2026-04
85/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology glucokinase shrna m lentiviral particles
Gαi1 and <t>Gαi3</t> DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)
Glucokinase Shrna M Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucokinase shrna m lentiviral particles/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
glucokinase shrna m lentiviral particles - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

94
European Directorate for the Quality of Medicines and HealthCare ethyl acetate fraction
Gαi1 and <t>Gαi3</t> DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)
Ethyl Acetate Fraction, supplied by European Directorate for the Quality of Medicines and HealthCare, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ethyl acetate fraction/product/European Directorate for the Quality of Medicines and HealthCare
Average 94 stars, based on 1 article reviews
ethyl acetate fraction - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology sp1 shrna m lentiviral particles
(A) Western blot analysis demonstrating the greater activities of hepatic AKT/mTOR pathways in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (B) Intraperitoneal insulin tolerance test (IPITT) and hepatic insulin signaling pathway show impaired insulin signaling in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (C) Protein and (D) mRNA expression of the hepatic IGF1 and IGF1R, the transcription factors <t>Sp1,</t> and Sp5 and (E) plasma IGF1 were are higher in Lrp6mut/mut compared to WT mice. (F) Protein and (G) mRNA expression of transcription factors Sp5, Sp1 and key enzymes of DNL are significantly altered after LRP6 silencing by <t>shRNA</t> in HepG2 cells. (H) Protein expression levels of Sp1, IGF1, and phosphorylation of AKT (pT308 and pS473) were significantly reduced by Sp1 knockdown in primary hepatocytes of WT and Lrp6mut/mut mice. *P < 0.05; **P < 0.01; ***P < 0.001. WT, wildtype; DNL, de novo lipogenesis. Error bars represent SD. See also Figure S6.
Sp1 Shrna M Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sp1 shrna m lentiviral particles/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
sp1 shrna m lentiviral particles - by Bioz Stars, 2026-04
85/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology galr3 shrna m lentiviral particles
The expression of <t>GALR3</t> and spexin in mouse eyes. a-c mRNA expression levels of Galr3 and spexin in the whole eye, retina, and eyecup of Rho P23H/+ and WT mice detected with RT-qPCR. d GALR3 immunoreactivity (red) detected in retinal cryosections of Rho P23H/+ and WT mice. RPE cells were detected with an antibody recognizing RPE65 protein (green). Nuclei were stained with DAPI (blue). Stars indicate regions with enhanced GALR3 expression. Scale bar, 50 μm. RPE retinyl pigment epithelium, IS inner segments, ONL outer nuclear layer, INL inner nuclear layer, GCL ganglion cell layer. e Quantification of GALR3 expression as a mean of red fluorescence intensity detected in retinal cryosections stained with anti-GALR3 antibody. Error bars represent standard deviation (S.D.). Statistically significant changes that were calculated with Student’s t-test are shown with asterisks, * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ .
Galr3 Shrna M Lentiviral Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/galr3 shrna m lentiviral particles/product/Santa Cruz Biotechnology
Average 94 stars, based on 1 article reviews
galr3 shrna m lentiviral particles - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology foxc2 shrna
The expression of <t>GALR3</t> and spexin in mouse eyes. a-c mRNA expression levels of Galr3 and spexin in the whole eye, retina, and eyecup of Rho P23H/+ and WT mice detected with RT-qPCR. d GALR3 immunoreactivity (red) detected in retinal cryosections of Rho P23H/+ and WT mice. RPE cells were detected with an antibody recognizing RPE65 protein (green). Nuclei were stained with DAPI (blue). Stars indicate regions with enhanced GALR3 expression. Scale bar, 50 μm. RPE retinyl pigment epithelium, IS inner segments, ONL outer nuclear layer, INL inner nuclear layer, GCL ganglion cell layer. e Quantification of GALR3 expression as a mean of red fluorescence intensity detected in retinal cryosections stained with anti-GALR3 antibody. Error bars represent standard deviation (S.D.). Statistically significant changes that were calculated with Student’s t-test are shown with asterisks, * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ .
Foxc2 Shrna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/foxc2 shrna/product/Santa Cruz Biotechnology
Average 85 stars, based on 1 article reviews
foxc2 shrna - by Bioz Stars, 2026-04
85/100 stars
  Buy from Supplier

88
Santa Cruz Biotechnology lentivirus
The expression of <t>GALR3</t> and spexin in mouse eyes. a-c mRNA expression levels of Galr3 and spexin in the whole eye, retina, and eyecup of Rho P23H/+ and WT mice detected with RT-qPCR. d GALR3 immunoreactivity (red) detected in retinal cryosections of Rho P23H/+ and WT mice. RPE cells were detected with an antibody recognizing RPE65 protein (green). Nuclei were stained with DAPI (blue). Stars indicate regions with enhanced GALR3 expression. Scale bar, 50 μm. RPE retinyl pigment epithelium, IS inner segments, ONL outer nuclear layer, INL inner nuclear layer, GCL ganglion cell layer. e Quantification of GALR3 expression as a mean of red fluorescence intensity detected in retinal cryosections stained with anti-GALR3 antibody. Error bars represent standard deviation (S.D.). Statistically significant changes that were calculated with Student’s t-test are shown with asterisks, * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ .
Lentivirus, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lentivirus/product/Santa Cruz Biotechnology
Average 88 stars, based on 1 article reviews
lentivirus - by Bioz Stars, 2026-04
88/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology ubc9
<t>Ubc9</t> interacts with and SUMOylates ROR-γt. a Lysate was prepared from cLPLs of WT mice and subjected to immunoprecipitation with anti–ROR-γt antibody or control IgG antibody. The precipitated proteins were subjected to SDS-PAGE and in-gel digestion. The resulting peptides were analyzed by high-resolution MS/MS. Ubc9 (SwissProt #P63280) was identified as a specific interactor of ROR-γt protein. An MS/MS spectrum of the peptide 50 GTPWEGGLFK 59 ([M + H] +2 = 546.27 m/z ) belonging to Ubc9 is shown. Observed b - and y- ions are indicated. b Lysates from cLPLs of WT mice were immunoprecipitated with anti-ROR-γt, anti-Ubc9 antibody, or control IgG antibody, and immunoblot analysis with antibody against ROR-γt or Ubc9 was performed. c Sequence alignment was conducted for ROR-γt. The box indicates the conserved SUMOylation (Ψ-K-X-D/E) motif. d Total cell lysates from 293 T cells transfected with Myc-Ubc9, HA-SUMO1, and either Flag-ROR-γt or Flag-K187R-ROR-γt were immunoprecipitated with anti-Flag antibody. The immunoprecipitates were analyzed by immunoblot assay with anti-HA antibody to detect the SUMOylated form of ROR-γt. e Total cell lysates from 293 T cells transfected with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-HA antibody to detect the SUMOylated form of ROR-γt. f Lysates were prepared from cLPLs of WT mice and immunoprecipitated with anti–ROR-γt antibody or control IgG antibody. The immunoprecipitates were immunoblotted with anti-SUMO1 antibody. The data are representative of three or more independent experiments
Ubc9, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ubc9/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
ubc9 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


HDAC2 in NSCs is a mediator for the role of neuronal nNOS–PSD-95 association in regulating the fate of NSCs. A, B, Immunoblots showing HDAC2 levels (n = 4; A) and bar graph showing the percentage of newborn neurons (n = 3; B) in the NSCs infected by LV-HDAC2-shRNA, LV-control-shRNA, AD-HDAC2-Flag, or AD-Flag. C, Bar graph showing the percentage of newborn neurons in the DG of rats infected by AD-HDAC2-Flag or AD-Flag (n = 9). These rats were subjected to MCAO at 24 h after virus infection and were killed for BrdU/DCX staining at day 14 after MCAO administration. D–F, Bar graphs showing the percentage of newborn neurons (D), the percentage of neurons with multineurites (E), and total neurite length per newborn neuron with multineurites (F) in the NSCs treated with DETA/NONOate (50 μm) with or without NO scavenger C-PTIO (10 μm) for 24 h at day 2 after differentiation. The cultures were stained 4–5 d after treatment. (n = 3). G, Nitrosylation of total proteins or HDAC2 in NSCs. NSCs were treated with 50 μm DETA/NONOate for the indicated times (G1), with 50 μm GSNO for 4 h (G2), or with 50 μm DETA/NONOate for 4 h (G3) at day 2 after differentiation (n = 4). PC, Positive control, in which the lysate of NSCs was treated with GSNO (200 μm) for 30 min; BSA, biotin-switch assay. H, Immunoblots showing HDAC2 levels in the NSCs treated with 50 μm DETA/NONOate for the indicated times at day 2 after differentiation. (n = 3–5). I, Bar graphs showing HDAC2 activity in the NSCs treated with 50 μm DETA/NONOate for the indicated times (left) or by 50 μm DETA/NONOate with or without 10 μm NO scavenger C-PTIO for 4 h (right) at day 2 after differentiation. n = 3–5. J, K, HDAC2 levels (J; n = 5) and enzymatic activity (K; n = 4) in the solo-cultured or neuron-cocultured NSCs with or without C-PTIO. All cultures were exposed to OGD for 2 h at day 2 after NSC differentiation, and the NSCs were collected 6 h after OGD finish. To measure HDAC2 in NSCs selectively, coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells. C-PTIO (10 μm) or vehicle was added to the medium of NSCs in wells at the start of OGD exposure. L, M, The percentage of newborn neurons (L) and the percentage of newborn neurons with multineurites (M) in the cocultures of LV-control-shRNA- or LV-HDAC2-shRNA-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h at day 2 after differentiation and stained at days 4∼5 after OGD (n = 4). N, O, Bar graphs showing the percentage of newborn neurons (N) and the percentage of newborn neurons with multineurites (O) in the cocultures of AD-HDAC2-flag- or AD-flag-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h and treated with 10 μm ZL006 for 26 h beginning at OGD administration, and were stained at days 4∼5 after OGD administration. n = 5. Data are the mean ± SEM. *p < 0.05, **p < 0.01, two-tailed t test for C, ANOVA for others.

Journal: The Journal of Neuroscience

Article Title: Interaction of nNOS with PSD-95 Negatively Controls Regenerative Repair after Stroke

doi: 10.1523/JNEUROSCI.1305-14.2014

Figure Lengend Snippet: HDAC2 in NSCs is a mediator for the role of neuronal nNOS–PSD-95 association in regulating the fate of NSCs. A, B, Immunoblots showing HDAC2 levels (n = 4; A) and bar graph showing the percentage of newborn neurons (n = 3; B) in the NSCs infected by LV-HDAC2-shRNA, LV-control-shRNA, AD-HDAC2-Flag, or AD-Flag. C, Bar graph showing the percentage of newborn neurons in the DG of rats infected by AD-HDAC2-Flag or AD-Flag (n = 9). These rats were subjected to MCAO at 24 h after virus infection and were killed for BrdU/DCX staining at day 14 after MCAO administration. D–F, Bar graphs showing the percentage of newborn neurons (D), the percentage of neurons with multineurites (E), and total neurite length per newborn neuron with multineurites (F) in the NSCs treated with DETA/NONOate (50 μm) with or without NO scavenger C-PTIO (10 μm) for 24 h at day 2 after differentiation. The cultures were stained 4–5 d after treatment. (n = 3). G, Nitrosylation of total proteins or HDAC2 in NSCs. NSCs were treated with 50 μm DETA/NONOate for the indicated times (G1), with 50 μm GSNO for 4 h (G2), or with 50 μm DETA/NONOate for 4 h (G3) at day 2 after differentiation (n = 4). PC, Positive control, in which the lysate of NSCs was treated with GSNO (200 μm) for 30 min; BSA, biotin-switch assay. H, Immunoblots showing HDAC2 levels in the NSCs treated with 50 μm DETA/NONOate for the indicated times at day 2 after differentiation. (n = 3–5). I, Bar graphs showing HDAC2 activity in the NSCs treated with 50 μm DETA/NONOate for the indicated times (left) or by 50 μm DETA/NONOate with or without 10 μm NO scavenger C-PTIO for 4 h (right) at day 2 after differentiation. n = 3–5. J, K, HDAC2 levels (J; n = 5) and enzymatic activity (K; n = 4) in the solo-cultured or neuron-cocultured NSCs with or without C-PTIO. All cultures were exposed to OGD for 2 h at day 2 after NSC differentiation, and the NSCs were collected 6 h after OGD finish. To measure HDAC2 in NSCs selectively, coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells. C-PTIO (10 μm) or vehicle was added to the medium of NSCs in wells at the start of OGD exposure. L, M, The percentage of newborn neurons (L) and the percentage of newborn neurons with multineurites (M) in the cocultures of LV-control-shRNA- or LV-HDAC2-shRNA-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h at day 2 after differentiation and stained at days 4∼5 after OGD (n = 4). N, O, Bar graphs showing the percentage of newborn neurons (N) and the percentage of newborn neurons with multineurites (O) in the cocultures of AD-HDAC2-flag- or AD-flag-infected NSCs with GFP+ neurons. The cocultures were subjected to OGD for 2 h and treated with 10 μm ZL006 for 26 h beginning at OGD administration, and were stained at days 4∼5 after OGD administration. n = 5. Data are the mean ± SEM. *p < 0.05, **p < 0.01, two-tailed t test for C, ANOVA for others.

Article Snippet: HDAC2 shRNA (m) lentiviral particles (LV-HDAC2 shRNA, Santa Cruz Biotechnology) are recommended for the inhibition of HDAC2 expression in mouse cells.

Techniques: Western Blot, Infection, shRNA, Control, Virus, Staining, Positive Control, Biotin Switch Assay, Activity Assay, Cell Culture, Membrane, Pore Size, Two Tailed Test

Association of nNOS–PSD-95 in neurons and consequent NO production may negatively regulate NSC fate via HDAC2-mediated histone deacetylation and NeuroD downregulation. A, B, Immunoblots showing acetyl-H4 (A) and NeuroD (B) levels in the NSCs treated by 50 μm DETA/NONOate with or without 10 μm C-PTIO for 8 h at day 2 after differentiation (n = 4). C, D, Immunoblots showing acetyl-H4 (C) and NeuroD (D) levels in the NSCs treated by 50 μm DETA/NONOate with or without 2 nm TSA (an HDAC inhibitor that was added 30 min before DETA/NONOate) for 8 h at day 2 after differentiation (n = 4). E, F, Immunoblots showing acetyl-H4 (E) and NeuroD (F) levels in the NSCs treated with 50 μm DETA/NONOate with or without LV-HDAC2-shRNA infection for 8 h at day 2 after differentiation (n = 4). DETA/NONOate was added at day 6 after LV-HDAC2-shRNA or LV-control-shRNA infection. G, H, Immunoblots (G) and immunofluorescence (H) showing acetylation of histone H4 in the NSCs cocultured with neurons after OGD. Coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells (n = 4). Data are the mean ± SEM. *p < 0.05, **p < 0.01, ANOVA.

Journal: The Journal of Neuroscience

Article Title: Interaction of nNOS with PSD-95 Negatively Controls Regenerative Repair after Stroke

doi: 10.1523/JNEUROSCI.1305-14.2014

Figure Lengend Snippet: Association of nNOS–PSD-95 in neurons and consequent NO production may negatively regulate NSC fate via HDAC2-mediated histone deacetylation and NeuroD downregulation. A, B, Immunoblots showing acetyl-H4 (A) and NeuroD (B) levels in the NSCs treated by 50 μm DETA/NONOate with or without 10 μm C-PTIO for 8 h at day 2 after differentiation (n = 4). C, D, Immunoblots showing acetyl-H4 (C) and NeuroD (D) levels in the NSCs treated by 50 μm DETA/NONOate with or without 2 nm TSA (an HDAC inhibitor that was added 30 min before DETA/NONOate) for 8 h at day 2 after differentiation (n = 4). E, F, Immunoblots showing acetyl-H4 (E) and NeuroD (F) levels in the NSCs treated with 50 μm DETA/NONOate with or without LV-HDAC2-shRNA infection for 8 h at day 2 after differentiation (n = 4). DETA/NONOate was added at day 6 after LV-HDAC2-shRNA or LV-control-shRNA infection. G, H, Immunoblots (G) and immunofluorescence (H) showing acetylation of histone H4 in the NSCs cocultured with neurons after OGD. Coculture was performed with neurons in membrane inserts (1 μm pore size) and NSCs in wells (n = 4). Data are the mean ± SEM. *p < 0.05, **p < 0.01, ANOVA.

Article Snippet: HDAC2 shRNA (m) lentiviral particles (LV-HDAC2 shRNA, Santa Cruz Biotechnology) are recommended for the inhibition of HDAC2 expression in mouse cells.

Techniques: Western Blot, shRNA, Infection, Control, Immunofluorescence, Membrane, Pore Size

Gαi1 and Gαi3 DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1 and Gαi3 DKO blocks BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A–F) WT or Gαi1/3-DKO MEFs were treated with BDNF (applied at the indicated concentrations for the indicated times) or with PDGF-BB (25 ng/mL) and were analyzed by Western blotting for the listed proteins. For Western blot assays, equal amounts of quantified protein lysates were loaded (30 μg per treatment) or the same set of lysate samples was run on identical gels. The indicated proteins were quantified using ImageJ software (A, C–E, and F; n = 5). *P < 0.001 by Student’s t test. Data are reported as mean ± SD. (G and H) Immunofluorescence analysis was performed to test p-Akt (G) and p-Erk1/2 (H). (Scale bars: 10 μm.)

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: Activation Assay, Western Blot, Software, Immunofluorescence

Gαi1 and Gαi3 are required for BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A and B) WT MEFs, Gαi1- or Gαi3-SKO MEFs, Gαi2-SKO MEFs, and Gαi1/3-DKO MEFs were treated with BDNF (25 ng/mL) for the indicated time and were analyzed by Western blot for the listed proteins. (C) DKO MEFs were transiently transfected with plasmids encoding EE-Gαi1-cDNA, EE-Gαi3-cDNA, or empty vector. MEFs were treated with BDNF (25 ng/mL) for the indicated time and were tested by Western blot for the listed proteins. (D) WT MEFs were transfected with 100 nM of scr-siRNA, Gαi1, or Gαi3 siRNA, and MEFs stably expressing CRISPR/Cas9-Gαi1 and CRISPR/Cas9-Gαi3 were treated with BDNF (25 ng/mL) and were tested by Western blot for the listed proteins. *P < 0.01 vs. WT MEFs (A) and vs. scr-siRNA (D). #P < 0.001 (A and D). #P < 0.001 vs. vector (C).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1 and Gαi3 are required for BDNF-induced Akt–mTORC1 and Erk activation in MEFs. (A and B) WT MEFs, Gαi1- or Gαi3-SKO MEFs, Gαi2-SKO MEFs, and Gαi1/3-DKO MEFs were treated with BDNF (25 ng/mL) for the indicated time and were analyzed by Western blot for the listed proteins. (C) DKO MEFs were transiently transfected with plasmids encoding EE-Gαi1-cDNA, EE-Gαi3-cDNA, or empty vector. MEFs were treated with BDNF (25 ng/mL) for the indicated time and were tested by Western blot for the listed proteins. (D) WT MEFs were transfected with 100 nM of scr-siRNA, Gαi1, or Gαi3 siRNA, and MEFs stably expressing CRISPR/Cas9-Gαi1 and CRISPR/Cas9-Gαi3 were treated with BDNF (25 ng/mL) and were tested by Western blot for the listed proteins. *P < 0.01 vs. WT MEFs (A) and vs. scr-siRNA (D). #P < 0.001 (A and D). #P < 0.001 vs. vector (C).

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: Activation Assay, Western Blot, Transfection, Plasmid Preparation, Stable Transfection, Expressing, CRISPR

Gαi1/3 are required for the TrkB adaptor complex formation. (A and B) WT and Gαi1/3-DKO MEFs were treated with BDNF (25 ng/mL) for 5 min, and the association among TrkB, Gαi3, and adaptor proteins was tested by the immunoprecipitation assay. Input control shows the expression of listed proteins in the total cell lysates. (C–E) WT MEFs, Gαi1- or Gαi3-SKO MEFs, and Gαi1/3-DKO MEFs (C), WT MEFs or Gαi1/3 MEFs transfected with shRNA or scr-shRNA (D), and WT and Gαi2-KO MEFs were treated with BDNF and p-Gab1 and were tested by Western blot analysis. β-Actin served as the loading control. (F) DKO MEFs were transiently transfected with vector encoding EE-Gαi1-cDNA, EE-Gαi3-cDNA, or empty vector, and BDNF (25 ng/mL)-induced Gab1 phosphorylation was analyzed by Western blot. (G) WT or Gab1-KO MEFs were treated with BDNF (25 ng/mL) for the indicated time and were analyzed by Western blotting for the listed proteins. *P < 0.001 vs. WT MEFs.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1/3 are required for the TrkB adaptor complex formation. (A and B) WT and Gαi1/3-DKO MEFs were treated with BDNF (25 ng/mL) for 5 min, and the association among TrkB, Gαi3, and adaptor proteins was tested by the immunoprecipitation assay. Input control shows the expression of listed proteins in the total cell lysates. (C–E) WT MEFs, Gαi1- or Gαi3-SKO MEFs, and Gαi1/3-DKO MEFs (C), WT MEFs or Gαi1/3 MEFs transfected with shRNA or scr-shRNA (D), and WT and Gαi2-KO MEFs were treated with BDNF and p-Gab1 and were tested by Western blot analysis. β-Actin served as the loading control. (F) DKO MEFs were transiently transfected with vector encoding EE-Gαi1-cDNA, EE-Gαi3-cDNA, or empty vector, and BDNF (25 ng/mL)-induced Gab1 phosphorylation was analyzed by Western blot. (G) WT or Gab1-KO MEFs were treated with BDNF (25 ng/mL) for the indicated time and were analyzed by Western blotting for the listed proteins. *P < 0.001 vs. WT MEFs.

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: Immunoprecipitation, Control, Expressing, Transfection, shRNA, Western Blot, Plasmid Preparation, Phospho-proteomics

Gαi1/3 are required for BDNF-induced signaling and TrkB adaptor complex formation in cerebellar granule neurons. (A and C) Lentiviral-mediated shRNA knockdown of Gαi1/3 disrupts downstream signaling. Primary cultured cerebellar granule neurons transduced with lentiviral Gαi1 shRNA plus Gαi3 shRNA or scr-shRNA for 24 h were treated with BDNF (25 ng/mL), and Akt, S6, MEK1/2–Erk1/2, SHP2, and Gab1 phosphorylation was analyzed by Western blotting. (B and D) Lentiviral-mediated shRNA knockdown of Gαi1/3 decreases the association between TrkB and Gαi1/3, SHP2, APPL1, and Gab1. Primary cerebellar granule neurons transduced with Gαi1 shRNA plus Gαi3 shRNA or scr-shRNA were stimulated with BDNF (25 ng/mL), and the association was tested by immunoprecipitation. *P < 0.001 vs. scr-shRNA.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1/3 are required for BDNF-induced signaling and TrkB adaptor complex formation in cerebellar granule neurons. (A and C) Lentiviral-mediated shRNA knockdown of Gαi1/3 disrupts downstream signaling. Primary cultured cerebellar granule neurons transduced with lentiviral Gαi1 shRNA plus Gαi3 shRNA or scr-shRNA for 24 h were treated with BDNF (25 ng/mL), and Akt, S6, MEK1/2–Erk1/2, SHP2, and Gab1 phosphorylation was analyzed by Western blotting. (B and D) Lentiviral-mediated shRNA knockdown of Gαi1/3 decreases the association between TrkB and Gαi1/3, SHP2, APPL1, and Gab1. Primary cerebellar granule neurons transduced with Gαi1 shRNA plus Gαi3 shRNA or scr-shRNA were stimulated with BDNF (25 ng/mL), and the association was tested by immunoprecipitation. *P < 0.001 vs. scr-shRNA.

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: shRNA, Knockdown, Cell Culture, Transduction, Phospho-proteomics, Western Blot, Immunoprecipitation

Gαi1/3 are required for BDNF signaling, endocytosis, and dendrite outgrowth in the hippocampal neurons. (A) Lentiviral-mediated shRNA knockdown of Gαi1/3 disrupts downstream TrkB signaling and TrkB endocytosis in primary hippocampal neurons. Hippocampal neurons were infected with lentiviral Gαi1 shRNA plus lentiviral Gαi3 shRNA (shGαi1/3) or a lentiviral scr-shRNA for 24 h. Neurons were stimulated with BDNF (25 ng/mL) and analyzed for the listed proteins in total and cell-surface lysates. (B and C) Lentiviral-mediated shRNA Gαi1/3 knockdown decreases dendrite morphology in primary hippocampal neurons. On day 5 after infection, neurons were stained for GFP expression (encoded by the lentiviral shRNA vectors), and the morphology of hippocampal neurons was quantified. (B) Representative images of anti-GFP staining are presented. Arrowheads indicate spines. (Scale bars: 25 μm; magnification: Inset, 6.8×.) (C) Dendrite length, branching, soma area, and the number of dendritic spines were quantified. For spine analysis, 30-μm-long dendritic segments (50–80 μm from soma) were selected, and spines from 40 neurons were counted. (D) A representative image of GFP expression 7 d after hippocampal injection of a lentiviral GFP control virus shows a high efficiency of infection. (E) Intrahippocampal lentiviral shRNA-mediated knockdown of Gαi1/3 decreases Akt and Erk1/2 activity, as analyzed by Western blotting with phospho-specific antibodies. Hippocampi were isolated and tested by Western blotting of listed proteins (n = 5). (F–I) Intrahippocampal lentiviral shRNA-mediated knockdown of Gαi1/3 decreases the formation of secondary dendrites and spines. (F and H) Representative images showing hippocampal neuron morphology are presented for control and shRNA Gαi1/3-infected neurons stained for GFP. Arrowheads in H indicate spines. (Scale bars: 25 μm in F and 5 μm in H.) (G) The number of neurons and dendrites per neuron were counted. (I) Spines were counted from 30-μm-long dendritic segments (50–80 μm from soma) of 40 randomly selected neurons. *P < 0.001 vs. GFP. #P < 0.001.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1/3 are required for BDNF signaling, endocytosis, and dendrite outgrowth in the hippocampal neurons. (A) Lentiviral-mediated shRNA knockdown of Gαi1/3 disrupts downstream TrkB signaling and TrkB endocytosis in primary hippocampal neurons. Hippocampal neurons were infected with lentiviral Gαi1 shRNA plus lentiviral Gαi3 shRNA (shGαi1/3) or a lentiviral scr-shRNA for 24 h. Neurons were stimulated with BDNF (25 ng/mL) and analyzed for the listed proteins in total and cell-surface lysates. (B and C) Lentiviral-mediated shRNA Gαi1/3 knockdown decreases dendrite morphology in primary hippocampal neurons. On day 5 after infection, neurons were stained for GFP expression (encoded by the lentiviral shRNA vectors), and the morphology of hippocampal neurons was quantified. (B) Representative images of anti-GFP staining are presented. Arrowheads indicate spines. (Scale bars: 25 μm; magnification: Inset, 6.8×.) (C) Dendrite length, branching, soma area, and the number of dendritic spines were quantified. For spine analysis, 30-μm-long dendritic segments (50–80 μm from soma) were selected, and spines from 40 neurons were counted. (D) A representative image of GFP expression 7 d after hippocampal injection of a lentiviral GFP control virus shows a high efficiency of infection. (E) Intrahippocampal lentiviral shRNA-mediated knockdown of Gαi1/3 decreases Akt and Erk1/2 activity, as analyzed by Western blotting with phospho-specific antibodies. Hippocampi were isolated and tested by Western blotting of listed proteins (n = 5). (F–I) Intrahippocampal lentiviral shRNA-mediated knockdown of Gαi1/3 decreases the formation of secondary dendrites and spines. (F and H) Representative images showing hippocampal neuron morphology are presented for control and shRNA Gαi1/3-infected neurons stained for GFP. Arrowheads in H indicate spines. (Scale bars: 25 μm in F and 5 μm in H.) (G) The number of neurons and dendrites per neuron were counted. (I) Spines were counted from 30-μm-long dendritic segments (50–80 μm from soma) of 40 randomly selected neurons. *P < 0.001 vs. GFP. #P < 0.001.

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: shRNA, Knockdown, Infection, Staining, Expressing, Injection, Control, Virus, Activity Assay, Western Blot, Isolation

Gαi1/3 knockdown in the hippocampus produces depressive behaviors. (A–C) CMS exposure decreases Gαi1 and Gαi3 expression in the hippocampus. Western blot analysis of Gαi1 and Gαi3 expression in the hippocampus (A) and cortex (B) of mice exposed to the CMS model for 14–56 d compared with control hippocampus (C). (D–F) Gαi1 shRNA or Gαi3 shRNA injection into the hippocampus elicited depressive behaviors. Immobility times in the FST (D) and TST (E) and sucrose water preference (F) were examined on day 7 after intrahippocampal injection of GFP or lentiviral Gαi1 shRNA and/or Gαi3 shRNA. (G–J) Exogenous Gαi3 expression in the hippocampus induces antidepressive behavior. On day 7 after intrahippocampal injection of Ad-GFP or Ad-Gαi3, immobility times in the FST (I) and TST (J) were tested, and then hippocampi were isolated and analyzed by Western blotting of the listed proteins (G and H). (K–M) Exogenous expression of Gαi3 reversed CMS-induced depressive behavior. The immobility times in the FST (K) and TST (L) and sucrose water preference (M) were tested in control and CMS mice with or without intrahippocampal injection of Ad-GFP or Ad-Gαi3. #P < 0.001 vs. GFP (D–F, I, and J). *P < 0.001 vs. control mice (K–M). #P < 0.001 (D–F and K–M).

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Gαi1/3 knockdown in the hippocampus produces depressive behaviors. (A–C) CMS exposure decreases Gαi1 and Gαi3 expression in the hippocampus. Western blot analysis of Gαi1 and Gαi3 expression in the hippocampus (A) and cortex (B) of mice exposed to the CMS model for 14–56 d compared with control hippocampus (C). (D–F) Gαi1 shRNA or Gαi3 shRNA injection into the hippocampus elicited depressive behaviors. Immobility times in the FST (D) and TST (E) and sucrose water preference (F) were examined on day 7 after intrahippocampal injection of GFP or lentiviral Gαi1 shRNA and/or Gαi3 shRNA. (G–J) Exogenous Gαi3 expression in the hippocampus induces antidepressive behavior. On day 7 after intrahippocampal injection of Ad-GFP or Ad-Gαi3, immobility times in the FST (I) and TST (J) were tested, and then hippocampi were isolated and analyzed by Western blotting of the listed proteins (G and H). (K–M) Exogenous expression of Gαi3 reversed CMS-induced depressive behavior. The immobility times in the FST (K) and TST (L) and sucrose water preference (M) were tested in control and CMS mice with or without intrahippocampal injection of Ad-GFP or Ad-Gαi3. #P < 0.001 vs. GFP (D–F, I, and J). *P < 0.001 vs. control mice (K–M). #P < 0.001 (D–F and K–M).

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: Knockdown, Expressing, Western Blot, Control, shRNA, Injection, Isolation

Severe depressive-like behaviors in Gαi1/3-DKO mice. (A) Depletion of Gαi1 and Gαi3 in the DKO mice disrupts signaling. The expression of the listed proteins in the CA1 hippocampus of WT and Gαi1/3-DKO mice was examined by Western blot analysis. (B–D) DKO mice display depressive behaviors. For both WT and Gαi1/3-DKO mice, the FST (B), TST (C), and sucrose water preference test (D) were performed. (E–J) Analysis of DKO hippocampal CA1 neuronal morphology. (E and H) Representative images of CA1 pyramidal hippocampal neuronal morphology. Arrowheads indicate spines. (Scale bars: 25 μm in E and 5 μm in H.) (F) The number of neurons in randomly selected 200 × 200 μm fields was counted. (G and I) The number of secondary dendrites (G) and spines (I) in 40 random neurons were counted. Spines were analyzed from 30-μm-long apical dendritic segments (50–80 μm from soma). (J) The maximum spine width of 200 spines from 10 randomly selected neurons was measured by Image J software. *P < 0.001 vs. WT mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus

doi: 10.1073/pnas.1722493115

Figure Lengend Snippet: Severe depressive-like behaviors in Gαi1/3-DKO mice. (A) Depletion of Gαi1 and Gαi3 in the DKO mice disrupts signaling. The expression of the listed proteins in the CA1 hippocampus of WT and Gαi1/3-DKO mice was examined by Western blot analysis. (B–D) DKO mice display depressive behaviors. For both WT and Gαi1/3-DKO mice, the FST (B), TST (C), and sucrose water preference test (D) were performed. (E–J) Analysis of DKO hippocampal CA1 neuronal morphology. (E and H) Representative images of CA1 pyramidal hippocampal neuronal morphology. Arrowheads indicate spines. (Scale bars: 25 μm in E and 5 μm in H.) (F) The number of neurons in randomly selected 200 × 200 μm fields was counted. (G and I) The number of secondary dendrites (G) and spines (I) in 40 random neurons were counted. Spines were analyzed from 30-μm-long apical dendritic segments (50–80 μm from soma). (J) The maximum spine width of 200 spines from 10 randomly selected neurons was measured by Image J software. *P < 0.001 vs. WT mice.

Article Snippet: Lentivirus with shRNA targeting murine Gαi1 (sc-41751-V; Santa Cruz Biotechnology) or murine Gαi3 (sc-37255-V; Santa Cruz Biotechnology) were added for 18 h. For stable cell lines, MEFs infected with the lentiviral Gαi1/3 shRNA were selected with puromycin (1.0 μg/mL).

Techniques: Expressing, Western Blot, Software

(A) Western blot analysis demonstrating the greater activities of hepatic AKT/mTOR pathways in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (B) Intraperitoneal insulin tolerance test (IPITT) and hepatic insulin signaling pathway show impaired insulin signaling in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (C) Protein and (D) mRNA expression of the hepatic IGF1 and IGF1R, the transcription factors Sp1, and Sp5 and (E) plasma IGF1 were are higher in Lrp6mut/mut compared to WT mice. (F) Protein and (G) mRNA expression of transcription factors Sp5, Sp1 and key enzymes of DNL are significantly altered after LRP6 silencing by shRNA in HepG2 cells. (H) Protein expression levels of Sp1, IGF1, and phosphorylation of AKT (pT308 and pS473) were significantly reduced by Sp1 knockdown in primary hepatocytes of WT and Lrp6mut/mut mice. *P < 0.05; **P < 0.01; ***P < 0.001. WT, wildtype; DNL, de novo lipogenesis. Error bars represent SD. See also Figure S6.

Journal: Cell metabolism

Article Title: The Combined Hyperlipidemia Caused by Impaired Wnt-LRP6 signaling is reversed by Wnt3a Rescue

doi: 10.1016/j.cmet.2013.11.023

Figure Lengend Snippet: (A) Western blot analysis demonstrating the greater activities of hepatic AKT/mTOR pathways in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (B) Intraperitoneal insulin tolerance test (IPITT) and hepatic insulin signaling pathway show impaired insulin signaling in Lrp6mut/mut compared to WT mice. The ratios of phosphorylated to total proteins by densitometry are shown. (C) Protein and (D) mRNA expression of the hepatic IGF1 and IGF1R, the transcription factors Sp1, and Sp5 and (E) plasma IGF1 were are higher in Lrp6mut/mut compared to WT mice. (F) Protein and (G) mRNA expression of transcription factors Sp5, Sp1 and key enzymes of DNL are significantly altered after LRP6 silencing by shRNA in HepG2 cells. (H) Protein expression levels of Sp1, IGF1, and phosphorylation of AKT (pT308 and pS473) were significantly reduced by Sp1 knockdown in primary hepatocytes of WT and Lrp6mut/mut mice. *P < 0.05; **P < 0.01; ***P < 0.001. WT, wildtype; DNL, de novo lipogenesis. Error bars represent SD. See also Figure S6.

Article Snippet: Cells were infected with Sp1 shRNA (m) lentiviral Particles (sc-29488-V, Santa Cruz Biotech) using polybrene to increase the efficiency of infection.

Techniques: Western Blot, Expressing, Clinical Proteomics, shRNA, Phospho-proteomics, Knockdown

The expression of GALR3 and spexin in mouse eyes. a-c mRNA expression levels of Galr3 and spexin in the whole eye, retina, and eyecup of Rho P23H/+ and WT mice detected with RT-qPCR. d GALR3 immunoreactivity (red) detected in retinal cryosections of Rho P23H/+ and WT mice. RPE cells were detected with an antibody recognizing RPE65 protein (green). Nuclei were stained with DAPI (blue). Stars indicate regions with enhanced GALR3 expression. Scale bar, 50 μm. RPE retinyl pigment epithelium, IS inner segments, ONL outer nuclear layer, INL inner nuclear layer, GCL ganglion cell layer. e Quantification of GALR3 expression as a mean of red fluorescence intensity detected in retinal cryosections stained with anti-GALR3 antibody. Error bars represent standard deviation (S.D.). Statistically significant changes that were calculated with Student’s t-test are shown with asterisks, * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: The expression of GALR3 and spexin in mouse eyes. a-c mRNA expression levels of Galr3 and spexin in the whole eye, retina, and eyecup of Rho P23H/+ and WT mice detected with RT-qPCR. d GALR3 immunoreactivity (red) detected in retinal cryosections of Rho P23H/+ and WT mice. RPE cells were detected with an antibody recognizing RPE65 protein (green). Nuclei were stained with DAPI (blue). Stars indicate regions with enhanced GALR3 expression. Scale bar, 50 μm. RPE retinyl pigment epithelium, IS inner segments, ONL outer nuclear layer, INL inner nuclear layer, GCL ganglion cell layer. e Quantification of GALR3 expression as a mean of red fluorescence intensity detected in retinal cryosections stained with anti-GALR3 antibody. Error bars represent standard deviation (S.D.). Statistically significant changes that were calculated with Student’s t-test are shown with asterisks, * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Expressing, Quantitative RT-PCR, Staining, Fluorescence, Standard Deviation

Effects of GALR3 inhibition on retinal morphology and the expression of structural proteins in Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at postnatal day 33 (P33) and P45. a Schematic of mouse treatment regimen with SNAP-37,889 antagonist. b The representative OCT images of the retina. Scale bar, 100 μm. c The representative histological retinal images stained with H&E. Scale bar, 50 μm. d Quantification of the outer nuclear layer (ONL) thickness at 500 mm from the optic nerve head (ONH). e mRNA expression levels of Rho and M-opsin detected with RT-qPCR. f Protein expression levels of RHO and M-Opsin assessed by immunoblotting. The representative immunoblots are shown. Full immunoblots are shown in Supplementary Information in Fig. <xref ref-type= S1 . g Quantification of protein bands intensities of RHO and M-Opsin detected in three independent immunoblot experiments, normalized to GAPDH. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− . GCL ganglion cell layer, INL inner nuclear layer, IS inner segments, OS outer segments. " width="100%" height="100%">

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on retinal morphology and the expression of structural proteins in Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at postnatal day 33 (P33) and P45. a Schematic of mouse treatment regimen with SNAP-37,889 antagonist. b The representative OCT images of the retina. Scale bar, 100 μm. c The representative histological retinal images stained with H&E. Scale bar, 50 μm. d Quantification of the outer nuclear layer (ONL) thickness at 500 mm from the optic nerve head (ONH). e mRNA expression levels of Rho and M-opsin detected with RT-qPCR. f Protein expression levels of RHO and M-Opsin assessed by immunoblotting. The representative immunoblots are shown. Full immunoblots are shown in Supplementary Information in Fig. S1 . g Quantification of protein bands intensities of RHO and M-Opsin detected in three independent immunoblot experiments, normalized to GAPDH. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− . GCL ganglion cell layer, INL inner nuclear layer, IS inner segments, OS outer segments.

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Expressing, Staining, Quantitative RT-PCR, Western Blot

Effects of GALR3 inhibition on retinal function in Rho P23H/+ mice. Retinal function was assessed with electroretinography (ERG) recordings in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33 and P45. Error bars represent S.D. Statistical analysis was performed with two-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on retinal function in Rho P23H/+ mice. Retinal function was assessed with electroretinography (ERG) recordings in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33 and P45. Error bars represent S.D. Statistical analysis was performed with two-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition

Effects of GALR3 inhibition on retinal inflammation in Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at postnatal day 33 (P33) and P45. a Detection of GFAP expression (red) (upper panel) and IBA-1 expression (red) (lower panel) in retinal cryosections at P33. Arrows indicate IBA-1-positive immune cells migrating to the outer retina. Detection of GFAP expression (red) (upper panel) and IBA-1 expression (red) (lower panel) in retinal cryosections at P45. Arrows indicate IBA-1-positive immune cells migrating to the outer retina (enlarged images are shown in Fig. ). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. Detection of GFAP and IBA-1 in retinal cryosections of WT mice is shown in Fig. . c Protein expression levels of GFAP in mouse eyes assessed by immunoblotting at P33 and P45. Full immunoblots are shown in Supplementary Information (Fig. ). d Quantification of protein bands intensities of GFAP detected in three independent immunoblot experiments, normalized to GAPDH. e Detection of IBA-1 positive cells (red) in retinal flat mounts at P33 and P45. f Quantification of IBA-1 positive cells in retinal flat mounts. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− . GCL ganglion cell layer, INL inner nuclear layer, ONL outer nuclear layer.

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on retinal inflammation in Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at postnatal day 33 (P33) and P45. a Detection of GFAP expression (red) (upper panel) and IBA-1 expression (red) (lower panel) in retinal cryosections at P33. Arrows indicate IBA-1-positive immune cells migrating to the outer retina. Detection of GFAP expression (red) (upper panel) and IBA-1 expression (red) (lower panel) in retinal cryosections at P45. Arrows indicate IBA-1-positive immune cells migrating to the outer retina (enlarged images are shown in Fig. ). Nuclei were stained with DAPI (blue). Scale bar, 50 μm. Detection of GFAP and IBA-1 in retinal cryosections of WT mice is shown in Fig. . c Protein expression levels of GFAP in mouse eyes assessed by immunoblotting at P33 and P45. Full immunoblots are shown in Supplementary Information (Fig. ). d Quantification of protein bands intensities of GFAP detected in three independent immunoblot experiments, normalized to GAPDH. e Detection of IBA-1 positive cells (red) in retinal flat mounts at P33 and P45. f Quantification of IBA-1 positive cells in retinal flat mounts. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− . GCL ganglion cell layer, INL inner nuclear layer, ONL outer nuclear layer.

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Expressing, Staining, Western Blot

Effects of GALR3 inhibition on NF-κB signaling in the eyes of Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33. a mRNA expression levels of Nf-κb , Nlrp3 , and Caspase-1 detected with RT-qPCR. b Immunofluorescence detection of NF-κB signaling components, including NF-κB, NLRP3, and Caspase-1 (red) in cryosections. Nuclei were stained with DAPI (blue). Scale bar, 50 μm. c Protein expression analysis of NF-κB signaling, including NF-κB, total IκB, and phosphorylated IκB (P-IκB) detected by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). d Quantification of protein bands intensities of NF-κB, IκB, and P-IκB detected from three independent immunoblot experiments, normalized to GAPDH. Fold change was calculated. Error bars represent S.D. e Detection of pro-Caspase-1 and cleaved (activated) Caspase-1 in retinal protein extracts by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on NF-κB signaling in the eyes of Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33. a mRNA expression levels of Nf-κb , Nlrp3 , and Caspase-1 detected with RT-qPCR. b Immunofluorescence detection of NF-κB signaling components, including NF-κB, NLRP3, and Caspase-1 (red) in cryosections. Nuclei were stained with DAPI (blue). Scale bar, 50 μm. c Protein expression analysis of NF-κB signaling, including NF-κB, total IκB, and phosphorylated IκB (P-IκB) detected by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). d Quantification of protein bands intensities of NF-κB, IκB, and P-IκB detected from three independent immunoblot experiments, normalized to GAPDH. Fold change was calculated. Error bars represent S.D. e Detection of pro-Caspase-1 and cleaved (activated) Caspase-1 in retinal protein extracts by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Expressing, Quantitative RT-PCR, Immunofluorescence, Staining, Western Blot

Effects of GALR3 inhibition on the expression of pro-inflammatory and anti-inflammatory markers in the eyes of Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33 and P45. a mRNA expression levels of pro-inflammatory cytokines detected with RT-qPCR. b mRNA expression levels of anti-inflammatory markers detected with RT-qPCR. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on the expression of pro-inflammatory and anti-inflammatory markers in the eyes of Rho P23H/+ mice. The analyses were performed in WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− mice at P33 and P45. a mRNA expression levels of pro-inflammatory cytokines detected with RT-qPCR. b mRNA expression levels of anti-inflammatory markers detected with RT-qPCR. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Expressing, Quantitative RT-PCR

Effects of GALR3 inhibition on oxidative stress in the eyes of Rho P23H/+ mice. The analyses were performed in the following groups of mice: WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− at P33 and P45. a mRNA expression levels of antioxidant markers detected with RT-qPCR. b Protein expression analysis of representative antioxidant enzymes, including catalase and GCLc, detected by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). c Quantification of protein bands intensities of catalase and GCLc detected from three independent immunoblot experiments, normalized to GAPDH. Fold change was calculated. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on oxidative stress in the eyes of Rho P23H/+ mice. The analyses were performed in the following groups of mice: WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− at P33 and P45. a mRNA expression levels of antioxidant markers detected with RT-qPCR. b Protein expression analysis of representative antioxidant enzymes, including catalase and GCLc, detected by immunoblotting. Full immunoblots are shown in Supplementary Information (Fig. ). c Quantification of protein bands intensities of catalase and GCLc detected from three independent immunoblot experiments, normalized to GAPDH. Fold change was calculated. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Expressing, Quantitative RT-PCR, Western Blot

Effects of GALR3 inhibition on BRB integrity in the eyes of Rho P23H/+ mice. The analyses were performed in the following groups of mice: WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− at P33 and P45. a Immunofluorescence labeling of ZO-1 on RPE/choroidal flat mounts. b Quantification of RPE cell-cell connections per area. c Detection of albumin leakage on retinal flat mounts with anti-albumin antibody conjugated to fluorescein. d Quantification of fluorescence intensity in retinal tissue. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on BRB integrity in the eyes of Rho P23H/+ mice. The analyses were performed in the following groups of mice: WT, Rho P23H/+ , antagonist-treated Rho P23H/+ , and Rho P23H/+ Galr3 −/− at P33 and P45. a Immunofluorescence labeling of ZO-1 on RPE/choroidal flat mounts. b Quantification of RPE cell-cell connections per area. c Detection of albumin leakage on retinal flat mounts with anti-albumin antibody conjugated to fluorescein. d Quantification of fluorescence intensity in retinal tissue. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001; ns, not statistically significant. P23H/+, Rho P23H/+ ; P23H/+ SNAP, Rho P23H/+ treated with antagonist; P23H/+ Galr3 −/− , Rho P23H/+ Galr3 −/− .

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, Immunofluorescence, Labeling, Fluorescence

Effects of GALR3 inhibition on photoreceptor cells exposed to microglia-mediated neurotoxicity in vitro. a Schematic of experimental design. BV-2 microglial cells were stimulated with LPS (1 µg/ml) for 24 h to induce an immune response. Conditioned media (cMedia) from LPS-treated BV-2 cells were collected and applied to photoreceptor-derived 661 W cells and Galr3 -silenced 661 W cells ( shGalr3 ) to assess secondary inflammatory effects. b LPS stimulation in BV-2 cells induced overexpression of the Galr3 receptor and significantly increased the expression of pro-inflammatory cytokines, supporting a role of GALR3 in microglial activation. c 661 W cells treated with LPS-conditioned media also showed upregulation of Galr3 and pro-inflammatory cytokines. In contrast, shGalr3 661 W cells showed suppressed Galr3 expression and attenuated inflammatory responses, suggesting a cell-autonomous contribution of Galr3 to photoreceptor inflammation. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Journal: Scientific Reports

Article Title: Inhibition of galanin receptor 3 slows down retina degeneration in retinitis pigmentosa through modulation of inflammatory and oxidative stress response

doi: 10.1038/s41598-026-38345-6

Figure Lengend Snippet: Effects of GALR3 inhibition on photoreceptor cells exposed to microglia-mediated neurotoxicity in vitro. a Schematic of experimental design. BV-2 microglial cells were stimulated with LPS (1 µg/ml) for 24 h to induce an immune response. Conditioned media (cMedia) from LPS-treated BV-2 cells were collected and applied to photoreceptor-derived 661 W cells and Galr3 -silenced 661 W cells ( shGalr3 ) to assess secondary inflammatory effects. b LPS stimulation in BV-2 cells induced overexpression of the Galr3 receptor and significantly increased the expression of pro-inflammatory cytokines, supporting a role of GALR3 in microglial activation. c 661 W cells treated with LPS-conditioned media also showed upregulation of Galr3 and pro-inflammatory cytokines. In contrast, shGalr3 661 W cells showed suppressed Galr3 expression and attenuated inflammatory responses, suggesting a cell-autonomous contribution of Galr3 to photoreceptor inflammation. Error bars represent S.D. Statistical analysis was performed with one-way ANOVA and post hoc Turkey’s tests. Statistically significant changes are shown with asterisks. * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001.

Article Snippet: The 661 W cells with silenced GALR3 were prepared using GALR3 shRNA (m) Lentiviral Particles (sc-40011-V) (Santa Cruz Biotechnology, Inc.) according to the manufacturer’s protocol.

Techniques: Inhibition, In Vitro, Derivative Assay, Over Expression, Expressing, Activation Assay

Ubc9 interacts with and SUMOylates ROR-γt. a Lysate was prepared from cLPLs of WT mice and subjected to immunoprecipitation with anti–ROR-γt antibody or control IgG antibody. The precipitated proteins were subjected to SDS-PAGE and in-gel digestion. The resulting peptides were analyzed by high-resolution MS/MS. Ubc9 (SwissProt #P63280) was identified as a specific interactor of ROR-γt protein. An MS/MS spectrum of the peptide 50 GTPWEGGLFK 59 ([M + H] +2 = 546.27 m/z ) belonging to Ubc9 is shown. Observed b - and y- ions are indicated. b Lysates from cLPLs of WT mice were immunoprecipitated with anti-ROR-γt, anti-Ubc9 antibody, or control IgG antibody, and immunoblot analysis with antibody against ROR-γt or Ubc9 was performed. c Sequence alignment was conducted for ROR-γt. The box indicates the conserved SUMOylation (Ψ-K-X-D/E) motif. d Total cell lysates from 293 T cells transfected with Myc-Ubc9, HA-SUMO1, and either Flag-ROR-γt or Flag-K187R-ROR-γt were immunoprecipitated with anti-Flag antibody. The immunoprecipitates were analyzed by immunoblot assay with anti-HA antibody to detect the SUMOylated form of ROR-γt. e Total cell lysates from 293 T cells transfected with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-HA antibody to detect the SUMOylated form of ROR-γt. f Lysates were prepared from cLPLs of WT mice and immunoprecipitated with anti–ROR-γt antibody or control IgG antibody. The immunoprecipitates were immunoblotted with anti-SUMO1 antibody. The data are representative of three or more independent experiments

Journal: Nature Communications

Article Title: SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2

doi: 10.1038/s41467-018-06924-5

Figure Lengend Snippet: Ubc9 interacts with and SUMOylates ROR-γt. a Lysate was prepared from cLPLs of WT mice and subjected to immunoprecipitation with anti–ROR-γt antibody or control IgG antibody. The precipitated proteins were subjected to SDS-PAGE and in-gel digestion. The resulting peptides were analyzed by high-resolution MS/MS. Ubc9 (SwissProt #P63280) was identified as a specific interactor of ROR-γt protein. An MS/MS spectrum of the peptide 50 GTPWEGGLFK 59 ([M + H] +2 = 546.27 m/z ) belonging to Ubc9 is shown. Observed b - and y- ions are indicated. b Lysates from cLPLs of WT mice were immunoprecipitated with anti-ROR-γt, anti-Ubc9 antibody, or control IgG antibody, and immunoblot analysis with antibody against ROR-γt or Ubc9 was performed. c Sequence alignment was conducted for ROR-γt. The box indicates the conserved SUMOylation (Ψ-K-X-D/E) motif. d Total cell lysates from 293 T cells transfected with Myc-Ubc9, HA-SUMO1, and either Flag-ROR-γt or Flag-K187R-ROR-γt were immunoprecipitated with anti-Flag antibody. The immunoprecipitates were analyzed by immunoblot assay with anti-HA antibody to detect the SUMOylated form of ROR-γt. e Total cell lysates from 293 T cells transfected with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-HA antibody to detect the SUMOylated form of ROR-γt. f Lysates were prepared from cLPLs of WT mice and immunoprecipitated with anti–ROR-γt antibody or control IgG antibody. The immunoprecipitates were immunoblotted with anti-SUMO1 antibody. The data are representative of three or more independent experiments

Article Snippet: Ubc9 (sc-36774-V), ROR-γt (sc-38881-V), and HDAC2 (sc-29346-V) shRNA lentiviral particles were purchased from Santa Cruz Biotechnology.

Techniques: Immunoprecipitation, Control, SDS Page, Tandem Mass Spectroscopy, Western Blot, Sequencing, Transfection

SUMOylation of ROR-γt inhibits IL-17 expression. a Data show heatmap visualization of upregulated genes determined by RNA seq analysis in ROR-γt –/– CD4 + T cells transduced with either WT ROR-γt or K187R-ROR-γt and differentiated under Th17-inducing conditions. b Real-time PCR analysis was conducted for IL-17a mRNA expression in ROR-γt –/– CD4 + T cells transduced with either WT ROR-γt or K187R-ROR-γt. The relative fold change in the mRNA levels of the genes was normalized against ROR-γt –/– cells as compared with lentivirus-transduced ROR-γt –/– cells. c ELISA was conducted for IL-17A secretion in the culture supernatant of ROR-γt –/– cells transduced with lentivirus encoding V5-tagged WT-ROR-γt or K187R-ROR-γt. d Immunoblot analysis of the expression of lentiviral constructs of V5-ROR-γt in ROR-γt –/– cells. e Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of the IL-17-promoter-driven luciferase plasmid (pGL4-mIL17p) and plasmid-encoded HA-SUMO1, Myc-Ubc9, Flag-ROR-γt, and/or Flag-K187R-ROR-γt. f Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of plasmid pGL4-mIL17p along with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A. Results are presented in relative luciferase units (RLU). g Data show Ubc9 knockdown by Ubc9-specific shRNA (shUbc9) or control shRNA (shCtrl) in WT cLPLs that were stimulated with PMA and ionomycin. ELISA was performed to measure IL-17A secretion in culture supernatant of Ubc9 knockdown cLPLs as well as immunoblotting showing knockdown of Ubc9. h ELISA was performed to measure the IL-17A secretion in the culture supernatant of Ubc9 knockdown cells expressing either WT-ROR-γt or K187R-ROR-γt. i Real-time PCR analysis for IL-17a mRNA expression, in which the relative fold change in the mRNA levels of the genes has been normalized against ROR-γt-expressing cells treated with control shRNA compared to Ubc9-specific shRNA. j Immunoblot analysis shows Ubc9 knockdown in CD4 + T cells expressing either WT-ROR-γt or K187R-ROR-γt. Data are from one experiment representative of three independent experiments with similar results. * p < 0.05, ** p < 0.01, ns: non-significant (two-tail t test) error bars are S.D.

Journal: Nature Communications

Article Title: SUMOylation of ROR-γt inhibits IL-17 expression and inflammation via HDAC2

doi: 10.1038/s41467-018-06924-5

Figure Lengend Snippet: SUMOylation of ROR-γt inhibits IL-17 expression. a Data show heatmap visualization of upregulated genes determined by RNA seq analysis in ROR-γt –/– CD4 + T cells transduced with either WT ROR-γt or K187R-ROR-γt and differentiated under Th17-inducing conditions. b Real-time PCR analysis was conducted for IL-17a mRNA expression in ROR-γt –/– CD4 + T cells transduced with either WT ROR-γt or K187R-ROR-γt. The relative fold change in the mRNA levels of the genes was normalized against ROR-γt –/– cells as compared with lentivirus-transduced ROR-γt –/– cells. c ELISA was conducted for IL-17A secretion in the culture supernatant of ROR-γt –/– cells transduced with lentivirus encoding V5-tagged WT-ROR-γt or K187R-ROR-γt. d Immunoblot analysis of the expression of lentiviral constructs of V5-ROR-γt in ROR-γt –/– cells. e Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of the IL-17-promoter-driven luciferase plasmid (pGL4-mIL17p) and plasmid-encoded HA-SUMO1, Myc-Ubc9, Flag-ROR-γt, and/or Flag-K187R-ROR-γt. f Luciferase assay was conducted of lysates from Jurkat T cells transfected with various combinations (below plot) of plasmid pGL4-mIL17p along with Flag-ROR-γt, HA-SUMO1, and either Myc-Ubc9 or Myc-Ubc9-C93A. Results are presented in relative luciferase units (RLU). g Data show Ubc9 knockdown by Ubc9-specific shRNA (shUbc9) or control shRNA (shCtrl) in WT cLPLs that were stimulated with PMA and ionomycin. ELISA was performed to measure IL-17A secretion in culture supernatant of Ubc9 knockdown cLPLs as well as immunoblotting showing knockdown of Ubc9. h ELISA was performed to measure the IL-17A secretion in the culture supernatant of Ubc9 knockdown cells expressing either WT-ROR-γt or K187R-ROR-γt. i Real-time PCR analysis for IL-17a mRNA expression, in which the relative fold change in the mRNA levels of the genes has been normalized against ROR-γt-expressing cells treated with control shRNA compared to Ubc9-specific shRNA. j Immunoblot analysis shows Ubc9 knockdown in CD4 + T cells expressing either WT-ROR-γt or K187R-ROR-γt. Data are from one experiment representative of three independent experiments with similar results. * p < 0.05, ** p < 0.01, ns: non-significant (two-tail t test) error bars are S.D.

Article Snippet: Ubc9 (sc-36774-V), ROR-γt (sc-38881-V), and HDAC2 (sc-29346-V) shRNA lentiviral particles were purchased from Santa Cruz Biotechnology.

Techniques: Expressing, RNA Sequencing, Transduction, Real-time Polymerase Chain Reaction, Enzyme-linked Immunosorbent Assay, Western Blot, Construct, Luciferase, Transfection, Plasmid Preparation, Knockdown, shRNA, Control